We provide our clients with world-class strategy to help them maximize impact and drive change.
Polling and Strategy for
Domestic & International Campaigns
GQR, a woman-owned business, helps progressive candidates campaign, win, and govern. You want to make an impact and win your race—don’t leave it to chance.
What we do best: creating compelling messages that evoke emotion and move your audience to action.
Digital & Social Media
We work with international and US campaigns to employ best practices to advance campaign goals. Our strategies put technology to use to tell your story, engage your audience wherever they may be, and move them to action. We assist international and domestic clients with a wide variety of digital support.
We start with science and use our opinion research to identify opportunities and weaknesses in a brand’s image, reputation, and messaging.
We bring a strategic decision-making approach to analytics. By combining polling experience with cutting-edge statistical techniques, we utilize a common sense approach to help campaigns, organizations, and corporations leverage data to understand and motivate their target audiences.
With days left, Black voters face orchestrated efforts to discourage voting
Pandemic PollWatch: Issue 19
In the 19th Pandemic PollWatch, GQR examines attitudes toward science and scientists, and the effects of coronavirus on elections in Kyrgyzstan, Lithuania, and the Czech Republic.
Pandemic PollWatch: Issue 18
GQR Global Survey for Freedom House Shows How the Pandemic is Also Causing a Crisis for Democracy
A new Freedom House report, based on a first-of-its-kind GQR survey, reveals a setback for democracy during the pandemic as many governments and authoritarian leaders respond to the health crisis with new abuses of power, the silencing of critics and opposition parties, increased corruption, and changes to election rules.
Pandemic PollWatch: Issue 17
Pandemic PollWatch returns with the 17th edition, examining economic issues slowly returning to the fore, and how a significant number remain resistant to a COVID-19 vaccine.